1.
Trope C, Andersson H, Björkholm E, Frankendal B, Himmelman A, Hogberg T, et al. Doxorubicin-Melphalan with and Without Cisplatin in Advanced Ovarian Cancer: Ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group. AO [Internet]. 1996 Jan. 1 [cited 2026 Jun. 24];35(Supp 8):109-18. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/30606